Nov 13, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Research Solutions Inc. ( RSSS ) Meets Q1 Earnings Estimates
Research Solutions (RSSS) delivered earnings and revenue surprises of 0.00% and +0.26%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Nov 07, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Karat Packing ( KRT ) Q3 Earnings Miss Estimates
Karat Packing (KRT) delivered earnings and revenue surprises of -5.13% and +0.42%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Nov 06, 2025 • Zacks Commentary
NEUTRAL
Albany International ( AIN ) Q3 Earnings Surpass Estimates
Albany International (AIN) delivered earnings and revenue surprises of +1.43% and -12.24%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 22, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
UniFirst ( UNF ) Surpasses Q4 Earnings and Revenue Estimates
UniFirst (UNF) delivered earnings and revenue surprises of +6.05% and +1.03%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 09, 2025 • Benzinga
NEUTRAL
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. ( NASDAQ: AMLX ) ; Humana Inc. ( NYSE: HUM ) ; Five Below, Inc. ( NASDAQ: FIVE ) ; and Vestis Corp. ( NYSE: VSTS ) : Grabar Law Office is Investigating Claims on Your Behalf - Five Below ( NASDAQ:FIVE ) , Amylyx Pharmaceuticals ( NASDAQ:AMLX )
PHILADELPHIA, Oct. 09, 2025 ( GLOBE NEWSWIRE ) -- Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) - Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) as securities fraud class action ...